200 related articles for article (PubMed ID: 36801104)
21. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis of Peptide-Based Antimicrobial Inhibition of a Resistance-Nodulation-Cell Division Multidrug Efflux Pump.
Lyu M; Ayala JC; Chirakos I; Su CC; Shafer WM; Yu EW
Microbiol Spectr; 2022 Oct; 10(5):e0299022. PubMed ID: 36121287
[TBL] [Abstract][Full Text] [Related]
23. A Novel Antimicrobial Peptide Derived from Bony Fish IFN1 Exerts Potent Antimicrobial and Anti-Inflammatory Activity in Mammals.
Xiao X; Lu H; Zhu W; Zhang Y; Huo X; Yang C; Xiao S; Zhang Y; Su J
Microbiol Spectr; 2022 Apr; 10(2):e0201321. PubMed ID: 35289673
[TBL] [Abstract][Full Text] [Related]
24. A Novel Cryptic Clostridial Peptide That Kills Bacteria by a Cell Membrane Permeabilization Mechanism.
Szadkowska M; Olewniczak M; Kloska A; Jankowska E; Kapusta M; Rybak B; Wyrzykowski D; Zmudzinska W; Gieldon A; Kocot A; Kaczorowska AK; Nierzwicki L; Makowska J; Kaczorowski T; Plotka M
Microbiol Spectr; 2022 Oct; 10(5):e0165722. PubMed ID: 36094301
[TBL] [Abstract][Full Text] [Related]
25. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of novel arylurea derivatives of aryloxy(1-phenylpropyl) alicyclic diamines with antimicrobial activity against multidrug-resistant Gram-positive bacteria.
Canale V; Czekajewska J; Klesiewicz K; Papież M; Kuziak A; Witek K; Piska K; Niemiec D; Kasza P; Pękala E; Empel J; Tomczak M; Karczewska E; Zajdel P
Eur J Med Chem; 2023 May; 251():115224. PubMed ID: 36958177
[TBL] [Abstract][Full Text] [Related]
27. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
Younis W; Thangamani S; Seleem MN
Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
Wong JP; DiTullio P; Parkinson S
Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
[TBL] [Abstract][Full Text] [Related]
31. Bioactive metabolites of
Abdelaziz R; Tartor YH; Barakat AB; El-Didamony G; Gado MM; Berbecea A; Radulov HDI
Front Cell Infect Microbiol; 2023; 13():1162721. PubMed ID: 37168394
[TBL] [Abstract][Full Text] [Related]
32. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
[TBL] [Abstract][Full Text] [Related]
33. A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.
Almaaytah A; Farajallah A; Abualhaijaa A; Al-Balas Q
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004427
[TBL] [Abstract][Full Text] [Related]
34.
Li Z; Shi L; Wang B; Wei X; Zhang J; Guo T; Kong J; Wang M; Xu H
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33361364
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
36. Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials.
Hoque J; Adhikary U; Yadav V; Samaddar S; Konai MM; Prakash RG; Paramanandham K; Shome BR; Sanyal K; Haldar J
Mol Pharm; 2016 Oct; 13(10):3578-3589. PubMed ID: 27589087
[TBL] [Abstract][Full Text] [Related]
37. Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.
Zhang Q; Xu Y; Wang Q; Hang B; Sun Y; Wei X; Hu J
Antimicrob Agents Chemother; 2015 May; 59(5):2835-41. PubMed ID: 25753638
[TBL] [Abstract][Full Text] [Related]
38. An ancient solution to a modern problem.
Davies JE; Behroozian S
Mol Microbiol; 2020 Mar; 113(3):546-549. PubMed ID: 32185831
[TBL] [Abstract][Full Text] [Related]
39. Molecular design of antimicrobial conjugated oligoelectrolytes with enhanced selectivity toward bacterial cells.
Limwongyut J; Nie C; Moreland AS; Bazan GC
Chem Sci; 2020 Jul; 11(31):8138-8144. PubMed ID: 34123085
[TBL] [Abstract][Full Text] [Related]
40. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
Adeniji OO; Nontongana N; Okoh JC; Okoh AI
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
